Gail Frances Mcintyre - Net Worth and Insider Trading
Gail Frances Mcintyre Net Worth
The estimated net worth of Gail Frances Mcintyre is at least $447 dollars as of 2024-11-13. Gail Frances Mcintyre is the CEO and President of Aravive Inc and owns about 11,137 shares of Aravive Inc (ARAV) stock worth over $447. Details can be seen in Gail Frances Mcintyre's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gail Frances Mcintyre has not made any transactions after 2021-06-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gail Frances Mcintyre
Gail Frances Mcintyre Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gail Frances Mcintyre owns 1 companies in total, including Aravive Inc (ARAV) .
Click here to see the complete history of Gail Frances Mcintyre’s form 4 insider trades.
Insider Ownership Summary of Gail Frances Mcintyre
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARAV | Aravive Inc | 2021-06-29 | Chief Scientific Officer |
Gail Frances Mcintyre Latest Holdings Summary
Gail Frances Mcintyre currently owns a total of 1 stock. Gail Frances Mcintyre owns 11,137 shares of Aravive Inc (ARAV) as of June 29, 2021, with a value of $447.
Latest Holdings of Gail Frances Mcintyre
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARAV | Aravive Inc | 2021-06-29 | 11,137 | 0.04 | 447 |
Holding Weightings of Gail Frances Mcintyre
Gail Frances Mcintyre Form 4 Trading Tracker
According to the SEC Form 4 filings, Gail Frances Mcintyre has made a total of 2 transactions in Aravive Inc (ARAV) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aravive Inc is the acquisition of 1,000 shares on June 29, 2021, which cost Gail Frances Mcintyre around $5,350.
Insider Trading History of Gail Frances Mcintyre
- 1
Gail Frances Mcintyre Trading Performance
GuruFocus tracks the stock performance after each of Gail Frances Mcintyre's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gail Frances Mcintyre is -8.72%. GuruFocus also compares Gail Frances Mcintyre's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gail Frances Mcintyre within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gail Frances Mcintyre's insider trading performs compared to the benchmark.
Performance of Gail Frances Mcintyre
Gail Frances Mcintyre Ownership Network
Ownership Network List of Gail Frances Mcintyre
Ownership Network Relation of Gail Frances Mcintyre
Gail Frances Mcintyre Owned Company Details
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Gail Frances Mcintyre is the Chief Scientific Officer of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
Gail Frances Mcintyre Mailing Address
Above is the net worth, insider trading, and ownership report for Gail Frances Mcintyre. You might contact Gail Frances Mcintyre via mailing address: C/o Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville Nc 27560.